CSIMarket Company Name, Ticker, Customers, else..
 
Therapeutic Solutions International Inc   (TSOI)
Other Ticker:  
 
 
Price: $0.0007 $0.00 16.667%
Day's High: $0.0007 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: -12.5 %
Volume (M): 352 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 4,512
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Therapeutic Solutions International Inc
Therapeutic Solutions International Inc is a biotechnology company that focuses on the development and commercialization of innovative medical treatments and therapies. The company is dedicated to finding solutions to various health conditions, including neurological disorders, chronic pain, and cancer. Therapeutic Solutions International Inc conducts research and clinical trials to develop new drugs and treatments, with a focus on utilizing the body's own immune system to fight illnesses. The company aims to provide effective and affordable healthcare solutions for patients worldwide.


   Company Address: 701 Wild Rose Lane Elk City 83525 ID
   Company Phone Number: 295-7208   Stock Exchange / Ticker: TSOI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Therapeutic Solutions International Inc

Therapeutic Solutions International Inc's Revenue Takes a Noticeable Dip in Q2 2023, signaling the need for strategic enhancements


As a financial journalist, I have closely analyzed the latest financial results of Therapeutic Solutions International Inc, which were announced for the fiscal interval closing June 30, 2023. The company's performance reveals a mixed bag of outcomes, with some areas showing improvement while others face challenges.
Highlighting the company's earnings per share (EPS), TSOI reached $0.00 per share, the same as the previous year but experienced a decline when compared to the preceding financial reporting period. This indicates that the company has maintained stability in terms of EPS, but there is room for improvement for future reporting periods.
Therapeutic Solutions International Inc

Dramatic Financial Plunge Stuns Therapeutic Solutions International Inc. in Q1 of 2023, Reports Reveals Shocking -72.76% Revenue Drop

Therapeutic Solutions International Inc, a pharmaceutical company, recently published its fiscal interval report ending on March 31, 2023. The report indicated that the company was able to maintain balanced books, showing no earnings or losses per share. This is the same as the previous fiscal year, but an improvement from the previous reporting period.
The company's revenue, on the other hand, decreased by 72.764% from $0.08 million in the comparative period to $0.02 million. However, sequentially, there was a significant increase of 169.53% from $0.01 million. This indicates that the company's financial performance has been unstable overall.






Therapeutic Solutions International Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com